DK3142672T3 - Amphotericin b-derivat med reduceret toksicitet - Google Patents
Amphotericin b-derivat med reduceret toksicitet Download PDFInfo
- Publication number
- DK3142672T3 DK3142672T3 DK15793421.7T DK15793421T DK3142672T3 DK 3142672 T3 DK3142672 T3 DK 3142672T3 DK 15793421 T DK15793421 T DK 15793421T DK 3142672 T3 DK3142672 T3 DK 3142672T3
- Authority
- DK
- Denmark
- Prior art keywords
- amphotericin
- derivative
- reduced toxicity
- toxicity
- reduced
- Prior art date
Links
- NYWPVFGILHJXGJ-QRHLAUAJSA-L copper;(1s,3r,4e,6e,8e,10e,12e,14e,16e,19r,25r,27r,30r,31r,33s,35r,38r)-3-(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carb Chemical compound [Cu+2].CC(C)C1=CC(C(C)C)=C(O)C(C([O-])=O)=C1.CC(C)C1=CC(C(C)C)=C(O)C(C([O-])=O)=C1.OC1C(N)C(O)C(C)OC1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(C)[C@@H](O)C(C)C(C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(CC(O)[C@H]2C(O)=O)O[C@H]2C1 NYWPVFGILHJXGJ-QRHLAUAJSA-L 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461994450P | 2014-05-16 | 2014-05-16 | |
| US201462045907P | 2014-09-04 | 2014-09-04 | |
| PCT/US2015/030965 WO2015175875A1 (en) | 2014-05-16 | 2015-05-15 | Amphotericin b derivative with reduced toxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3142672T3 true DK3142672T3 (da) | 2019-10-21 |
Family
ID=54480735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15793421.7T DK3142672T3 (da) | 2014-05-16 | 2015-05-15 | Amphotericin b-derivat med reduceret toksicitet |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9738677B2 (enExample) |
| EP (1) | EP3142672B1 (enExample) |
| JP (1) | JP6543272B2 (enExample) |
| CA (1) | CA2981288C (enExample) |
| DK (1) | DK3142672T3 (enExample) |
| ES (1) | ES2749927T3 (enExample) |
| WO (1) | WO2015175875A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6755859B2 (ja) * | 2014-10-17 | 2020-09-16 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | アムホテリシンｂの毒性が低減された誘導体の規模変更可能な合成法 |
| US9957290B2 (en) | 2015-04-15 | 2018-05-01 | Sfunga Therapeutics, Inc. | Derivatives of amphotericin B |
| KR102893040B1 (ko) | 2018-09-07 | 2025-11-27 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 독성이 감소된 혼성 암포테리신 b 유도체 |
| AU2020325054A1 (en) * | 2019-08-08 | 2022-03-03 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
| EP4009968A4 (en) * | 2019-08-09 | 2023-08-16 | The Board Of Trustees Of The University Of Illinois | Combination treatment of systemic fungal infections |
| WO2022035752A1 (en) * | 2020-08-10 | 2022-02-17 | The Board Of Trustees Of The University Of Illinois | Hybrid amide derivatives of amphotericin b |
| CA3261962A1 (en) * | 2022-07-08 | 2024-01-11 | The Board Of Trustees Of The University Of Illinois | TRANSFER OF C2 EPIMERIZED SUGARS TO AGLYCONIC AMPHOTEROCIBN B |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1641480A1 (en) * | 2003-05-27 | 2006-04-05 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| JP2008503586A (ja) * | 2004-06-21 | 2008-02-07 | ネクター セラピューティクス | アンフォテリシンｂを含む組成物、方法、およびシステム |
| US8513204B2 (en) | 2004-06-21 | 2013-08-20 | Novartis Ag | Compositions comprising amphotericin B, mehods and systems |
| WO2014059436A1 (en) * | 2012-10-12 | 2014-04-17 | The Board Of Trustees Of The University Of Illinois | Electronic tuning of site selectivity |
| JP6755859B2 (ja) * | 2014-10-17 | 2020-09-16 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | アムホテリシンｂの毒性が低減された誘導体の規模変更可能な合成法 |
-
2015
- 2015-05-15 CA CA2981288A patent/CA2981288C/en active Active
- 2015-05-15 EP EP15793421.7A patent/EP3142672B1/en active Active
- 2015-05-15 ES ES15793421T patent/ES2749927T3/es active Active
- 2015-05-15 US US15/310,815 patent/US9738677B2/en active Active
- 2015-05-15 WO PCT/US2015/030965 patent/WO2015175875A1/en not_active Ceased
- 2015-05-15 DK DK15793421.7T patent/DK3142672T3/da active
- 2015-05-15 JP JP2016567865A patent/JP6543272B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170088572A1 (en) | 2017-03-30 |
| WO2015175875A1 (en) | 2015-11-19 |
| EP3142672B1 (en) | 2019-09-25 |
| ES2749927T3 (es) | 2020-03-24 |
| JP2017518982A (ja) | 2017-07-13 |
| EP3142672A1 (en) | 2017-03-22 |
| CA2981288C (en) | 2022-12-06 |
| CA2981288A1 (en) | 2015-11-19 |
| US9738677B2 (en) | 2017-08-22 |
| JP6543272B2 (ja) | 2019-07-10 |
| EP3142672A4 (en) | 2017-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| DK3137843T3 (da) | Projektil med forbedret ballistik | |
| LT3236972T (lt) | Antivirusiniai n4-hidroksicitidino dariniai | |
| DK4032440T3 (da) | Låganordning | |
| LT3204359T (lt) | Tetrahidroizochinolino dariniai | |
| CL2016002461A1 (es) | Derivados macrocíclicos de pirimidina | |
| DK3168219T3 (da) | Pyridonderivat med tetrahydropyranylmethylgruppe | |
| HUE048321T2 (hu) | Karabazol származékok | |
| DK3231803T3 (da) | Dihydroindolizinonderivat | |
| LT3371168T (lt) | Indolin-2-ono dariniai | |
| HRP20190336T1 (hr) | Derivati 6-alkinilpiridina kao smac-mimetici | |
| DK3143479T3 (da) | Driftkompensering med parallel minimering | |
| DK3142672T3 (da) | Amphotericin b-derivat med reduceret toksicitet | |
| DK3131898T3 (da) | Fluoroalkylfluorenderivativer | |
| EP3309163A4 (en) | SUBSTITUTED DIHYDROPYRROLO PYRAZOL DERIVATIVE | |
| DE112014006148A5 (de) | Schubladenausziehführung | |
| EP3372589A4 (en) | pyrimidine derivative | |
| EP4059379C0 (en) | Drawer | |
| PL3137460T3 (pl) | Pochodne diheterocyklu połączonego cykloalkilem | |
| LT3097076T (lt) | Nauji cip-eikozanoidų dariniai | |
| DE112015002884A5 (de) | Schublade | |
| DK3380136T4 (da) | Autoinjektor | |
| DK3247496T3 (da) | Udsugningsapparat med reguleret udsugningsindretning | |
| IL252908A0 (en) | Fumagillol derivatives | |
| DE112015004761A5 (de) | Kombinationsmöbel |